Gary Rothbard, MD, MS

An international group of frontline physicians formulated guidelines regarding the triage and management of patients with acute coronary syndrome during the COVID-19 pandemic.

Recommendations by ASAIO on the selection and treatment of patients with respiratory and circulatory failure associated with COVID-19 using artificial pulmonary and/or cardiac support.

Significant associations were detected between right heart strain parameters and mean pulmonary arterial pressure and pulmonary capillary wedge pressure in patients with pulmonary hypertension.

Patients who died from COVID-19 presented mainly with pulmonary disease involving diffuse alveolar damage that led to acute respiratory insufficiency.

With the initial surge of COVID-19 pandemic easing across the United States, safe reintroduction of cardiovascular diagnostic imaging will be crucial.

A set of guidelines regarding the use of multimodality cardiovascular imaging in young adult competitive athleteswas formulated by an expert writing group.

Canagliflozin was not found to be inferior to glimepiride for the treatment of patients with type 2 diabetes mellitus and stable congestive heart failure.

A history of myocardial infarction was found to be associated with enhanced risk for cardiovascular death, particularly sudden death.

Greater capacities in 3 key measures of high-density lipoprotein functionality were found to be associated with a reduced risk for cardiovascular disease.

Timely primary percutaneous coronary intervention should remain to be first line treatment for patients presenting to the emergency department with acute STEMI during the COVID-19 pandemic.